Markets
Stocks
Funds
Sectors
Tools
Overview
Market News
Market Videos
Currencies
International
Treasury & Bonds
Recent Quotes
My Watchlist
Indicators
Nasdaq Biotechnology Ishares ETF (NQ: IBB)
105.80 USD  -1.09 (-1.02%)
Streaming Delayed Price  /  Updated: 3:01 PM EDT, Jun 26, 2019  /  Add to My Watchlist      
View: Quote News
Fund Overview
Nasdaq Biotechnology Ishares ETF
Sector
Exchange Traded NQ
Net Assets 9.20B
Inception Date
Related Funds
Quote
Price 105.80
Volume 1,060,371
Last Trade Jun 26, 3:01pm
Change (%)
-1.09 (-1.02%)
Prev. Close 106.89
YTD %
+8.51%
Dividend Yield 0.30%
Performance
YTD
+8.30 (8.51%)
1 Month
+2.90 (2.82%)
3 Month
-4.53 (-4.11%)
6 Month
+10.99 (11.59%)
1 Year
-4.40 (-3.99%)
Chart
Charting
Chart for (: )
 
Intraday
1 Week
1 Month
3 Month
1 Year
  
Compare to:
The Daily Biotech Pulse: Decision Day For Regeneron-Sanofi, Vermillion Offering, PDL BioPharma CFO to Depart
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech stocks hitting ... Read More
from Benzinga
Weakness To Be Expected
It should be no surprise that that market was weak on Tuesday. Read More
from Blogs - TalkMarkets
Top News
More News
The Daily Biotech Pulse: Genfit NASH Drug In China, Conatus Explores Sale, Gilead Stitches Up Immuno-Oncology Partnership
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech stocks hitting ... Read More
from Benzinga
FDA Type A Meetings: What You Need To Know
Nabriva Therapeutics PLC – ADR (NASDAQ: NBRV) shares traded higher last week after the micro-cap biotech said it requested a Type ... Read More
from Benzinga
The 5 Most Expensive Drugs In US: What You Should Know
The upward trajectory of prescription drug prices in the U.S.has drawn the ire of lawmakers. Prices of drugs are staggeringly high ... Read More
from Benzinga
The Week Ahead In Biotech: Conferences, PDUFA Dates, Clinical Trial Readouts And IPOs
Biotech stocks came made upward moveslast week after a rangebound period. Among big pharma companies, Merck & Co., ... Read More
from Benzinga
The Daily Biotech Pulse: ContraVir's Volatile Ride Continues, Late-Stage Disappointment For Exelixis, Regeneron-Sanofi Breathe Easy
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech stocks hitting ... Read More
from Benzinga
IBB Makes Bullish Cross Above Critical Moving Average
In trading on Thursday, shares of the iShares Nasdaq Biotechnology ETF (IBB) crossed above their 200 day moving average of $108.53, changing hands as high as $110.18 per share. iShares Nasdaq... Read More
from ETF Channel
The Daily Biotech Pulse: DiaMedica Reports Positive Data For Chronic Kidney Disease Drug, Eloxx Offering, IPO Deluge
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech stocks hitting ... Read More
from Benzinga
Silver to Gold Ratio-Tip of the Inflation Iceberg
With the prospect of the Federal Reserve lowering rates later this year, we could see inflation indicators also flip. Read More
from Blogs - TalkMarkets
Biotech Stocks Heat Up, Driving ETF Gains
Biotechs ETFs created some heat yesterday as The SPDR S&P Biotech ETF and the iShares Nasdaq Biotechnology ETF, two popular exchange-traded funds tracking the biotechnology space, jumped on Monday... Read More
from ETF Trends
The Daily Biotech Pulse: Positive Readouts From Adamas And Ironwood, Sesen Bio To Offer Shares, Stoke Therapeutics Debut
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech stocks Hitting ... Read More
from Benzinga
ContraVir’s stock plunges after seesaw week of upbeat drug studies, mistaken filings and withdrawals of withdrawals
Shares of ContraVir Pharmaceuticals Inc. plunged Tuesday, to cap off a whipsaw week for investors that included upbeat results of a drug study, filings indicating the withdrawal, and a withdrawal of... Read More
from MarketWatch
Biotech ETFs Jump: Keep an Eye on XBI, IBB & SBIO
Biotech ETFs are movin’ on up on news that Pfizer is buying Array BioPharma for over $10 billion. SPDR S&P Biotech (XBI), iShares Nasdaq Biotechnology ETF (IBB), and ALPS Medical Breakthroughs ETF... Read More
from ETF Trends
The Daily Biotech Pulse: PhaseBio Pumped Up, Eiger Exults On Breakthrough Therapy Designation, Biohaven Slips On Stock Sale
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech stocks hitting ... Read More
from Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Six Financial & Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.